Pancreatic ductal adenocarcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who underwent distal pancreatectomy between January 2006 and December 2015
Exclusion criteria
Exclusion criteria: 1. R2 resection 2. Carcinoma in situ Rejection by the patients or proxy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hazard ratio of preoperative EUS-FNA for recurrence free survival in patients undergoing distal pancreatectomy for pancreatic adenocarcinoma | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency of gastric and peritoneal cancer recurrence | — |
Countries
Japan
Contacts
Teine-Keijinkai Hospital Center for gastroenterology